Ignacio
Gil Bazo
Investigador fins a 2022
Hospital Clinic Barcelona
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Clinic Barcelona (4)
2023
-
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
Thrombosis Research, Vol. 232, pp. 133-137
2020
-
Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors
Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282
2018
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781
2014
-
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors
Cancer Treatment Reviews, Vol. 40, Núm. 8, pp. 990-1004